Pricing and Valuation
Pricing models for developing pricing strategy based on interaction between pricing, cost-effectiveness, positioning and sales forecast.
Pricing Matrix Model weg model: An assessment of the pricing potential of the new product based on its clinical and economic product attributes.
Valuation of biotechnology, nutrition, and other healthcare innovation using the Discounted Cash Flow Model based on the free cash flows and the required cost of capital.
The inclusion of the estimated effects on economic value of the new emerging requirements for reimbursement authorities and payers and the effects of drug policy changes.
The assement and comprehension of key clinical and economic price drivers in relation to market access potential.